ZBED3 and non-small cell lung carcinoma: Based on these findings, we suggest that while Zbed3 and Wnt signalling molecules, including Axin, GSK3β, and β‐catenin, are all potential therapeutic targets, there remains a need for further investigation to fully understand the interaction of these molecules in NSCLC.